SALIARY IMMUNE RESPONSE TO COMMENSAL ORAL BACTERIA
对口腔共生细菌的唾液免疫反应
基本信息
- 批准号:6175874
- 负责人:
- 金额:$ 22.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-12-01 至 2003-05-31
- 项目状态:已结题
- 来源:
- 关键词:Streptococcus mitis antibody antigen antibody reaction bacteria infection mechanism bacterial antigens breast feeding clinical research colostrums dental plaque enzyme linked immunosorbent assay genetic strain genotype human subject immune tolerance /unresponsiveness immunoglobulin A infant human (0-1 year) longitudinal human study mouth mucosal immunity oral bacteria phenotype saliva western blottings
项目摘要
The indigenous microbiota of the mouth and other mucosal surfaces exists in homeostasis with the host except when perturbed, the mucosal surface damaged or the immune system compromised. Then, commensal bacteria are capable of causing severe opportunistic infections. Adaptive humoral immunity at mucosal surfaces principally is effected by secretory immunoglobulin A (SIgA) that is thought to play a role in the regulation of commensal bacteria. However, despite the fact that saliva contains SIgA antibodies reactive with commensal bacteria, these microorganisms colonize and persist on mucosal and tooth surfaces. This suggests that indigenous oral bacteria are unaffected by, not subjected to, or are able to avoid immune elimination by mucosal antibodies. This assertion is supported by data published by others showing that the acquisition and composition of the oral and intestinal indigenous microbiota of mice lacking mucosal SIgA and their litter mates do not differ, and that colonization of mice by commensal enteric bacteria appears to generate a self-limiting mucosal immune response resulting in a state of chronic hypo-responsiveness. During the previous funding period we have demonstrated, in a longitudinal study of human infants from birth to two years of age, that the commensal oral bacterium, S. mitis biovar 1, induces a limited antibody response in saliva with salivary SIgA antibodies reactive with this bacterium showing a significant decline from birth to two years of age. Furthermore, this bacterium demonstrated extensive genetic diversity and evidence of clonal replacement. Concomitantly, Western blots of envelope antigens of type strains of this bacterium showed a similar high degree of variability. In this competing continuation, the hypothesis to be tested is that commensal bacteria persist in the mouth by inducing a limited salivary SIgA antibody response due to antigenic variation mediated via clonal replacement. Employing a longitudinal study of infants from birth to 12 months, the Specific Aims are to (1) analyze the clonal diversity of S. mitis biovar 1 obtained from shedding surfaces within the infants' mouth and (2) analyze the diversity of SIgA antibodies in each infants' saliva reactive with their own S. mitis biovar 1 isolates. This work should provide important information concerning colonization of the human mouth by pioneer bacteria and may demonstrate the ability of SIgA to influence the presence of specific bacterial clones.
口腔和其他粘膜表面的固有微生物群与宿主保持稳态,除非受到干扰,粘膜表面受损或免疫系统受损。 然后,肠道细菌能够引起严重的机会性感染。 粘膜表面的适应性体液免疫主要受分泌型免疫球蛋白A(SIgA)的影响,分泌型免疫球蛋白A被认为在肠道细菌的调节中起作用。 然而,尽管唾液中含有与口腔细菌反应的SIgA抗体,但这些微生物在粘膜和牙齿表面上定殖并持续存在。 这表明本土口腔细菌不受粘膜抗体的影响,不受粘膜抗体的影响,或者能够避免粘膜抗体的免疫消除。 其他人发表的数据支持了这一论断,这些数据显示缺乏粘膜SIgA的小鼠及其同窝小鼠的口腔和肠道固有微生物群的获得和组成没有差异,并且肠道细菌对小鼠的定殖似乎产生自限性粘膜免疫应答,导致慢性低应答状态。 在上一个资助期间,我们已经证明,在一项对人类婴儿从出生到两岁的纵向研究中,口腔细菌,S。缓症菌生物变型1在唾液中诱导有限的抗体应答,与该细菌反应的唾液SIgA抗体显示出从出生到两岁的显著下降。 此外,该细菌表现出广泛的遗传多样性和克隆替代的证据。同时,这种细菌的模式菌株的包膜抗原的蛋白质印迹显示出类似的高度变异性。在这种竞争性的延续中,待检验的假设是,由于通过克隆替代介导的抗原变异,唾液细菌通过诱导有限的唾液SIgA抗体应答而在口腔中持续存在。 本研究采用出生至12个月婴儿的纵向研究,具体目的是:(1)分析沙门氏菌的克隆多样性;从婴儿口腔内脱落表面获得的缓症链球菌生物变种1,以及(2)分析每个婴儿唾液中与他们自己的沙门氏菌反应的SIgA抗体的多样性。缓症菌生物变种1分离株。 这项工作应该提供重要的信息,关于殖民化的人类口腔的先锋细菌,并可能证明SIgA的能力,影响特定的细菌克隆的存在。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL F. COLE其他文献
MICHAEL F. COLE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL F. COLE', 18)}}的其他基金
RESOLVING WHITE MATTER TRACTS IN THE HUMAN BRAIN USING DIFFUSION WEIGHTED MAGNE
使用扩散加权磁解析人脑中的白质束
- 批准号:
7956197 - 财政年份:2009
- 资助金额:
$ 22.65万 - 项目类别:
RESOLVING WHITE MATTER TRACTS IN THE HUMAN BRAIN USING DIFFUSION WEIGHTED MAGNE
使用扩散加权磁解析人脑中的白质束
- 批准号:
7723336 - 财政年份:2008
- 资助金额:
$ 22.65万 - 项目类别:
HOST-C ALBICANS INTERACTION AT MUCOSAL SURFACES IN AIDS
艾滋病中宿主-C 白色念珠菌在粘膜表面的相互作用
- 批准号:
6100305 - 财政年份:1999
- 资助金额:
$ 22.65万 - 项目类别:
HOST-C ALBICANS INTERACTION AT MUCOSAL SURFACES IN AIDS
艾滋病中宿主-C 白色念珠菌在粘膜表面的相互作用
- 批准号:
6099885 - 财政年份:1998
- 资助金额:
$ 22.65万 - 项目类别:
HOST-C ALBICANS INTERACTION AT MUCOSAL SURFACES IN AIDS
艾滋病中宿主-C 白色念珠菌在粘膜表面的相互作用
- 批准号:
6235304 - 财政年份:1997
- 资助金额:
$ 22.65万 - 项目类别:
SALIVARY IMMUNE RESPONSE TO COMMENSAL ORAL BACTERIA
对口腔共生细菌的唾液免疫反应
- 批准号:
3221956 - 财政年份:1988
- 资助金额:
$ 22.65万 - 项目类别:
SALIVARY IMMUNE RESPONSE TO COMMENSAL ORAL BACTERIA
对口腔共生细菌的唾液免疫反应
- 批准号:
2129982 - 财政年份:1988
- 资助金额:
$ 22.65万 - 项目类别:
SALIVARY IMMUNE RESPONSE TO COMMENSAL ORAL BACTERIA
对口腔共生细菌的唾液免疫反应
- 批准号:
3221958 - 财政年份:1988
- 资助金额:
$ 22.65万 - 项目类别:
SALIARY IMMUNE RESPONSE TO COMMENSAL ORAL BACTERIA
对口腔共生细菌的唾液免疫反应
- 批准号:
2908092 - 财政年份:1988
- 资助金额:
$ 22.65万 - 项目类别:
SALIVARY IMMUNE RESPONSE TO COMMENSAL ORAL BACTERIA
对口腔共生细菌的唾液免疫反应
- 批准号:
3221957 - 财政年份:1988
- 资助金额:
$ 22.65万 - 项目类别:
相似海外基金
Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
- 批准号:
502607 - 财政年份:2024
- 资助金额:
$ 22.65万 - 项目类别:
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
- 批准号:
EP/Y024540/1 - 财政年份:2024
- 资助金额:
$ 22.65万 - 项目类别:
Fellowship
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
- 批准号:
MR/Y008847/1 - 财政年份:2024
- 资助金额:
$ 22.65万 - 项目类别:
Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
- 批准号:
BB/Y002180/1 - 财政年份:2024
- 资助金额:
$ 22.65万 - 项目类别:
Research Grant
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
- 批准号:
502578 - 财政年份:2024
- 资助金额:
$ 22.65万 - 项目类别:
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 22.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
- 批准号:
MR/Y003616/1 - 财政年份:2024
- 资助金额:
$ 22.65万 - 项目类别:
Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
- 批准号:
MR/Y033698/1 - 财政年份:2024
- 资助金额:
$ 22.65万 - 项目类别:
Research Grant
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
- 批准号:
23H03716 - 财政年份:2023
- 资助金额:
$ 22.65万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis research of anti-Sez6l2 antibody associated encephalopathy
抗Sez6l2抗体相关脑病的分析研究
- 批准号:
23K06940 - 财政年份:2023
- 资助金额:
$ 22.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)